Cargando…

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment

The aim of this study was to investigate whether tolerance-induced protection of islets in the renal subcapsular space can also prevent subcutaneous allogeneic islets from being rejected. We used bone marrow stem cells from C57BL/6 (H2(b)) mice to construct donor chimerism in conditioned diabetic BA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Brend Ray-Sea, Fu, Shin-Huei, Wang, Aline Yen Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497654/ https://www.ncbi.nlm.nih.gov/pubmed/28713424 http://dx.doi.org/10.1155/2017/7057852

Ejemplares similares

GLP-1 receptor agonist exenatide restores atypical antipsychotic clozapine treatment-associated glucose dysregulation and damage of pancreatic islet beta cells in mice
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2016)

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022)

Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication
por: Chen, Szu-Tah, et al.
Publicado: (2012)

PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
por: Harrington, Stephen, et al.
Publicado: (2022)

Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression
por: Wang, Xi, et al.
Publicado: (2022)

Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes
por: Huang, Chung‐Huei, et al.
Publicado: (2016)

A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin
por: Huang, Chung-Huei, et al.
Publicado: (2018)

Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival
por: Mastroianni, Melissa, et al.
Publicado: (2018)

Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9
por: Ding, Yunchuan, et al.
Publicado: (2009)

Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival
por: Kudo, Hiroya, et al.
Publicado: (2014)

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
por: Prodeus, Aaron, et al.
Publicado: (2014)

Genome-edited allogeneic donor “universal” chimeric antigen receptor T cells
por: Qasim, Waseem
Publicado: (2023)

Immunosuppressive effect of arsenic trioxide on islet xenotransplantation prolongs xenograft survival in mice
por: Zhao, Bin, et al.
Publicado: (2018)

Chimerism through the activation of invariant natural killer T cells prolongs graft survival after transplantation of induced pluripotent stem cell–derived allogeneic cardiomyocytes
por: Yoshida, Shohei, et al.
Publicado: (2022)

Fibroblasts accelerate islet revascularization and improve long-term graft survival in a mouse model of subcutaneous islet transplantation
por: Perez-Basterrechea, Marcos, et al.
Publicado: (2017)

Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
por: Headen, Devon M., et al.
Publicado: (2018)

Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo
por: Cai, Songjie, et al.
Publicado: (2020)

Induction of Chimerism Permits Low-Dose Islet Grafts in the Liver or Pancreas to Reverse Refractory Autoimmune Diabetes
por: Zhang, Chunyan, et al.
Publicado: (2010)

Allogeneic grafts of spontaneous canine melanomas and their cell culture strains in neonatal immunosuppressed dogs.
por: Betton, G. R., et al.
Publicado: (1976)

3-D Imaging Reveals Participation of Donor Islet Schwann Cells and Pericytes in Islet Transplantation and Graft Neurovascular Regeneration
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2015)

Subcutaneous device-free islet transplantation
por: Zhou, Xudong, et al.
Publicado: (2023)

Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
por: Wallace, Christopher Glenn, et al.
Publicado: (2012)

G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts
por: Zoso, Alessia, et al.
Publicado: (2016)

Donor Islet Endothelial Cells in Pancreatic Islet Revascularization
por: Nyqvist, Daniel, et al.
Publicado: (2011)

The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023)

Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022)

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation
por: Patel, Khilna, et al.
Publicado: (2016)

Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet‐transplantation enhances immediate post‐transplant islet graft function but not long‐term normoglycemia
por: Smink, Alexandra M., et al.
Publicado: (2017)

Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease
por: de Araújo, Renata Lins Fuentes, et al.
Publicado: (2014)

Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report
por: Yang, Hae Kyung, et al.
Publicado: (2015)

Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants
por: Li, Ying, et al.
Publicado: (2021)

Local Dexamethasone Administration Delays Allogeneic Islet Graft Rejection in the Anterior Chamber of the Eye of Non-Human Primates
por: Tun, Sai Bo Bo, et al.
Publicado: (2022)

Adipose-derived cellular therapies prolong graft survival in an allogenic hind limb transplantation model
por: Chen, Jingting, et al.
Publicado: (2021)

Hair Follicle Dermal Sheath Derived Cells Improve Islet Allograft Survival without Systemic Immunosuppression
por: Wang, Xiaojie, et al.
Publicado: (2015)

Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression
por: Siemionow, Maria, et al.
Publicado: (2023)

Clinical Allogeneic and Autologous Islet Cell Transplantation: Update
por: Matsumoto, Shinichi
Publicado: (2011)

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016)

Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation
por: Pathak, Shiva, et al.
Publicado: (2021)

Improved donor chimerism in relapse myelofibrosis post allogenic stem cell transplant with azacitidine and oral decitabine—First case report
por: Cheung, Verna, et al.
Publicado: (2022)

Engineering transferrable microvascular meshes for subcutaneous islet transplantation
por: Song, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_efb4lmekmnl17oiga6esudb6af